The RAX/PACT-PKR Stress Response Pathway Promotes P53 Sumoylation and Activation, Leading to G₁ Arrest

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2012 Jan 5

PMID 22214662

Citations 26

Authors

Richard L Bennett

Yu Pan

Jaime Christian

Teng Hui

W Stratford May Jr

Affiliations

Soon will be listed here.

Abstract

Cellular stresses, including growth factor deprivation, inflammatory cytokines or viral infection promote RAX/PACT-dependent activation of the double-stranded RNA-dependent protein kinase, PKR, to phosphorylate eIF2α, resulting in translation inhibition and apoptosis. In addition, PKR has been reported to regulate p53, STAT1 and NFκB. Here, we report that RAX/PACT interacts with the SUMO E2 ligase Ubc9 to stimulate p53-Ubc9 association and reversible p53 sumoylation on lysine 386. In addition, expression of RAX/PACT in a variety of cell lines promotes p53 stability and activity to increase p53 target gene expression. Significantly, while the expression of RAX/PACT, PKR or p53 alone has little effect on the cell cycle of p53-null H1299 cells, co-expression of p53 with either RAX/PACT or PKR promotes a 25-35% increase of cells in G₁. In contrast, co-expression of RAX/PACT with the sumoylation-deficient p53(K386R) mutant or with the desumoylase SENP1 fails to induce such a G₁ arrest. Furthermore, co-expression of p53, RAX/PACT and the dominantnegative PKR(K296R) mutant inhibits RAX/PACT-induced, p53-dependent G₁ growth arrest and expression of RAX/PACT in pkr(+/+) but not pkr(-/-) MEF cells promotes p53 and p21 expression following gamma irradiation. Significantly, p53 stability is decreased in cells with reduced RAX/PACT or PKR following doxorubicin treatment, and expression of exogenous RAX/ PACT promotes phosphorylation of wild-type but not p53(K386R) on serine 392. Collectively, results indicate that, in response to stress, the RAX/PACT-PKR signaling pathway may inhibit p53 protein turnover by a sumoylation-dependent mechanism with promotion of p53 phosphorylation and translational activation leading to G₁ cell cycle arrest.

Citing Articles

Luteolin protects DYT- cells from apoptosis by suppressing PKR activation.

Frederick K, Patel R Front Pharmacol. 2023; 14:1118725.

PMID: 36874028 PMC: 9974672. DOI: 10.3389/fphar.2023.1118725.

PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation.

Wei L, Wang W, Yao J, Cui Z, Xu Z, Ding H Oncogene. 2022; 41(37):4282-4294.

PMID: 35974143 DOI: 10.1038/s41388-022-02431-6.

Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.

Yang L, Lin K, Zhu L, Wang H, Teng S, Huang L Commun Biol. 2022; 5(1):822.

PMID: 35970927 PMC: 9378715. DOI: 10.1038/s42003-022-03778-y.

Cell Death and the p53 Enigma During Mammalian Embryonic Development.

Raj S, Jaiswal S, DePamphilis M Stem Cells. 2022; 40(3):227-238.

PMID: 35304609 PMC: 9199838. DOI: 10.1093/stmcls/sxac003.

Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis.

Lu Y, Yang Y, Hu T, Duan W Transl Cancer Res. 2022; 10(2):806-816.

PMID: 35116411 PMC: 8799081. DOI: 10.21037/tcr-20-2531.

References

Chen L, Chen J . MDM2-ARF complex regulates p53 sumoylation. Oncogene. 2003; 22(34):5348-57. DOI: 10.1038/sj.onc.1206851. View

Stehmeier P, Muller S . Regulation of p53 family members by the ubiquitin-like SUMO system. DNA Repair (Amst). 2009; 8(4):491-8. DOI: 10.1016/j.dnarep.2009.01.002. View

Patel C, Handy I, Goldsmith T, Patel R . PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem. 2000; 275(48):37993-8. DOI: 10.1074/jbc.M004762200. View

Matic I, Macek B, Hilger M, Walther T, Mann M . Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution. J Proteome Res. 2008; 7(9):4050-7. DOI: 10.1021/pr800368m. View

Kalejta R, Brideau A, Banfield B, Beavis A . An integral membrane green fluorescent protein marker, Us9-GFP, is quantitatively retained in cells during propidium iodide-based cell cycle analysis by flow cytometry. Exp Cell Res. 1999; 248(1):322-8. DOI: 10.1006/excr.1999.4427. View

Meurs E, Chong K, Galabru J, Thomas N, Kerr I, Williams B . Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 1990; 62(2):379-90. DOI: 10.1016/0092-8674(90)90374-n. View

Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R . The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell. 2006; 22(6):783-794. DOI: 10.1016/j.molcel.2006.05.016. View

Cheema A, Knights C, Rao M, Catania J, Perez R, Simons B . Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD. J Cell Physiol. 2010; 225(2):371-84. PMC: 3614007. DOI: 10.1002/jcp.22224. View

Muller S, Berger M, Lehembre F, Seeler J, Haupt Y, Dejean A . c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem. 2000; 275(18):13321-9. DOI: 10.1074/jbc.275.18.13321. View

10.

Ito T, Jagus R, May W . Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A. 1994; 91(16):7455-9. PMC: 44419. DOI: 10.1073/pnas.91.16.7455. View

11.

Menendez S, Goh A, Camus S, Ng K, Kua N, Badal V . MDM4 downregulates p53 transcriptional activity and response to stress during differentiation. Cell Cycle. 2011; 10(7):1100-8. DOI: 10.4161/cc.10.7.15090. View

12.

Van Dyke T . p53 and tumor suppression. N Engl J Med. 2007; 356(1):79-81. DOI: 10.1056/NEJMcibr066301. View

13.

Carter S, Bischof O, Dejean A, Vousden K . C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol. 2007; 9(4):428-35. DOI: 10.1038/ncb1562. View

14.

Wong A, Tam N, Yang Y, Cuddihy A, Li S, Kirchhoff S . Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 1997; 16(6):1291-304. PMC: 1169727. DOI: 10.1093/emboj/16.6.1291. View

15.

Chen G, Ma C, Bower K, Ke Z, Luo J . Interaction between RAX and PKR modulates the effect of ethanol on protein synthesis and survival of neurons. J Biol Chem. 2006; 281(23):15909-15. DOI: 10.1074/jbc.M600612200. View

16.

Stindt M, Carter S, Vigneron A, Ryan K, Vousden K . MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle. 2011; 10(18):3176-88. PMC: 3218624. DOI: 10.4161/cc.10.18.17436. View

17.

Bonnet M, Weil R, Dam E, Hovanessian A, Meurs E . PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol. 2000; 20(13):4532-42. PMC: 85837. DOI: 10.1128/MCB.20.13.4532-4542.2000. View

18.

DAcquisto F, Ghosh S . PACT and PKR: turning on NF-kappa B in the absence of virus. Sci STKE. 2001; 2001(89):re1. DOI: 10.1126/stke.2001.89.re1. View

19.

Rodriguez M, Desterro J, Lain S, Midgley C, Lane D, Hay R . SUMO-1 modification activates the transcriptional response of p53. EMBO J. 1999; 18(22):6455-61. PMC: 1171708. DOI: 10.1093/emboj/18.22.6455. View

20.

Chang K, Cai Z, Zhang C, Sen G, Williams B, Luo G . Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J Virol. 2006; 80(15):7364-74. PMC: 1563689. DOI: 10.1128/JVI.00586-06. View